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Diacylglycerol (DAG) is a versatile molecule that par-
ticipates as substrate in the synthesis of structural and
energetic lipids, and acts as the physiological signal that
activates protein kinase C. Diacylglycerol acyltrans-
ferase (DGAT), the last committed enzyme in triacyl-
glycerol synthesis, could potentially regulate the con-
tent and use of both signaling and glycerolipid substrate
DAG by converting it into triacylglycerol. To test this
hypothesis, we stably overexpressed the DGAT1 mouse
gene in human lung SV40-transformed fibroblasts
(DGAT cells), which contains high levels of DAG. DGAT
cells exhibited a 3.9-fold higher DGAT activity and a
3.2-fold increase in triacylglycerol content, whereas
DAG and phosphatidylcholine decreased by 70 and 20%,
respectively, compared with empty vector-transfected
SV40 cells (Control cells). Both acylation and de novo
synthesis of phosphatidylcholine, phosphatidylethanol-
amine, and sphingomyelin were reduced by 30–40% in
DGAT cells compared with controls, suggesting that
DGAT used substrates for triacylglycerol synthesis that
had originally been destined to produce phospholipids.
The incorporation of [14C]DAG and [14C]fatty acids re-
leased from plasma membrane by additions of either
phospholipase C or phospholipase A2 into triacylglyc-
erol was increased by 6.2- and 2.8-fold, respectively, in
DGAT cells compared with control cells, indicating that
DGAT can attenuate signaling lipids. Finally, DGAT
overexpression reversed the neoplastic phenotype be-
cause it dramatically reduced the cell growth rate and
suppressed the anchorage-independent growth of the
SV40 cells. These results strongly support the view that
DGAT participates in the regulation of membrane lipid
synthesis and lipid signaling, thereby playing an impor-
tant role in modulating cell growth properties.
Amphipatic lipids, such as diacylglycerols (DAG)1 and acyl-
CoAs exhibit dual actions, as substrates for membrane and
energy storage glycerolipids, as well as second messengers for
signaling transduction events. As a substrate for de novo glyc-
erolipid synthesis, DAG is a common intermediate for both
triacylglycerol and phospholipid synthesis. Studies performed
with permeabilized cells indicate that the utilization of de novo
synthesized DAG for either neutral or polar lipid synthesis is
controlled by DGAT and CDP-choline (ethanolamine) phospho-
transferase activities, suggesting the presence of a common
DAG pool that is shared for both lipid synthetic routes (1).
Nevertheless, at least one other DAG pool is available for
glycerolipid synthesis, because DAG that is released from tri-
acylglycerol stores in human fibroblasts can be converted to
phospholipids (2). Moreover, hepatic cells might contain differ-
ent DAG pools that are used to synthesize triacylglycerol for
storage or for lipoproteins (3, 4). Although no definitive evi-
dence exists for specific DAG pools for polar and neutral glyc-
erolipid synthetic pathways, segregation of DAG toward differ-
ent metabolic routes seems to occur according to the need of the
cell. For instance, when phospholipid synthesis is inhibited,
DAG originally destined to form phospholipids is re-directed
toward triacylglycerol (5).
Growth factors and hormones activate phospholipases C and
D to promote a bi-phasic accumulation of DAG that triggers
signaling events (6). As a signaling effector, DAG regulates cell
growth and differentiation by activating several isoforms of
protein kinase C (PKC). A short-term release of DAG is caused
by the hydrolysis of phosphatidylinositol by several isoforms of
phosphoinositide-specific PLC (7). A second wave of DAG pro-
duced by cytokine-activated PC hydrolysis is needed to fully
develop mitogenesis. In this regard, quiescent fibroblasts
treated with platelet-derived growth factor or bacterial PC-
PLC increase DAG levels and a concomitant strong mitogenic
response (8). Persistent accumulation of intracellular DAG has
also been linked to oncogenic transformation. Thus, sustained
high levels of DAG produced by overactivation of PC-PLC in-
duce a transformed phenotype in NIH 3T3 cells (9). Moreover,
neoplastic transformation by simian virus 40 (sv40), and by
ras-, src-, and fps oncogenes is accompanied by an excess con-
tent of intracellular DAG (10–12).
Not only are appropriate intracellular levels of signaling
DAG necessary for mitogenesis, but a proper supply of DAG
substrate for glycerolipid synthesis is also required by prolif-
erating cells. To prepare for mitosis, cells must synthesize new
membrane phospholipids; hence precursors for phospholipid
synthesis must be available. Thus, mitogenic signals stimulate
the formation of new PC by activating the expression of CTP:
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phosphocholine cytidylyltransferase (13) and by diverting DAG
toward PC synthesis, rather than triacylglycerol formation (5).
Moreover, in neurite outgrowth induced by nerve growth fac-
tor, PC synthesis is enhanced by an increase in DAG levels
together with an activation of the CDP-choline DAG phospho-
transferase (14). Membrane lipid synthesis is also up-regulated
in neoplastic cells, hence a constant supply of lipid precursors
for new membranes is required to sustain the unrestricted
proliferation of tumor cells. In this regard, increased synthesis
and turnover of phospholipids has been observed in neoplastic
cells (10, 11, 15).
Cells can regulate the content and destiny of DAG by lipol-
ysis (16), phosphorylation by DAG kinases (17–20), and syn-
thesis of PC (21). DAG released from plasma membrane may
also be directly incorporated into triacylglycerol, suggesting the
presence of a novel mechanism for terminating DAG signals
based on the synthesis of a storage lipid (22).
A key enzyme involved in DAG and triacylglycerol metabo-
lism is acyl-CoA-diacylglycerol acyltransferase 1 (DGAT1) (23).
DGAT1, and the recently discovered DGAT2 (24), catalyze the
last committed step in mammalian triacylglycerol synthesis by
esterifying DAG with a fatty acid. The DAG used as a DGAT
substrate is primarily derived from the de novo glycerol 3-phos-
phate pathway. Other sources of DAG for triacylglycerol syn-
thesis include that produced from monoacylglycerol in intesti-
nal cells (25), from the hydrolysis of triacylglycerol (2, 3), and
from DAG released from plasma membrane phospholipids (22).
Because both DGAT genes are widely expressed in mouse and
human tissues (23, 24), the presence of two DGAT enzymes in
non-adipose tissues suggests that the synthesis of triacylglyc-
erol might be linked to cell functions other than energy storage.
For instance, adenoviral expression of DGAT1 in pancreatic
islets increased the formation of triacylglycerol by 100% but
impaired the secretion of insulin after glucose stimulation (26).
To understand the role of DGAT in terminating DAG signals,
we tested the hypothesis that DGAT overexpression channels
DAG and/or fatty acids toward triacylglycerol, thereby seques-
tering either proliferative lipid signals and/or lipid substrates
for membrane biogenesis with a consequent decrease in phos-
pholipid synthesis, normalization of cell proliferation, and a
reversion in the abnormal cytological phenotype.
EXPERIMENTAL PROCEDURES
Materials—Normal human lung fibroblasts (WI38) and the derived
SV40-transformed strain were obtained from the American Type Cul-
ture Collection (Manassas, VA). LipofectAMINETM, cell culture media,
G418 (GeneticinTM) antibiotic, and other culture reagents were from
Invitrogen. Ultrafiltered fetal bovine serum (FBS) was from Gensa
(Buenos Aires, Argentina). Cell culture supplies were from Greiner
BioOne (Frickenhausen, Germany). Restriction enzymes and other mo-
lecular biology reagents were purchased from Promega (Madison, WI).
[14C]Oleic acid and [g-32P]ATP were from Amersham Biosciences,
[methyl-14C]choline and [3H]glycerol were purchased from PerkinElmer
Life Sciences. Fatty acid-free bovine serum albumin (BSA), phospho-
lipase A2 (PLA2, from Naja naja), PC-specific phospholipase C (PC-
PLC, from Bacillus cereus), and anti-FLAG M2 monoclonal antibody
were from Sigma. Pure lipid standards were from Doosan Serdary
(Yongin, Korea). 1,6-Diphenyl-1,3,5-hexatriene was purchased from
Aldrich. Silica Gel 60 chromatography plates were from Merck
(Darmstadt, Germany). Analytical-grade solvents were from Carlo
Erba (Milano, Italy). DAG kinase membrane suspension was from
Calbiochem.
Cell Culture—Cells were routinely cultured in 100-mm Petri dishes
in minimum essential medium with Earle’s salts (MEM) with 10%
heat-inactivated FBS, 1% penicillin (100 units/ml), streptomycin (10
mg/ml), 1% nonessential amino acids, and 1% MEM vitamins (growing
medium), at 37 °C, 5% CO2, and 100% humidity. Normal human lung
fibroblasts were used for the experiments before reaching the 20th
passage.
Generation of Stable DGAT1 Overexpressing SV40-transformed
Cells—Mouse DGAT1 cDNA with an N-terminal FLAG epitope (kind
gift of Dr. Robert V. Farese Jr., Gladstone Institute of Cardiovascular
Disease, University of California) was cloned into the restriction sites
EcoRV and XbaI of a pCDNA3 mammalian expression vector (Invitro-
gen). SV40-transformed cells, grown in 100-mm dishes up to 50% con-
fluence, were washed twice with serum-free Opti-MEM and then trans-
fected with 12 mg of either DGAT1-pCDNA3 plasmid or empty vector
plus 35 ml of LipofectAMINETM (2 mg/ml) in 0.5 ml of Opti-MEM plus
20% FBS. After 5 h incubation, medium was replaced by 10% FBS MEM
and transfected cells were grown for an additional 24 h. Then, positive
transfectants were selected by culturing the cells in 10% FBS, MEM
containing geneticin (600 mg/ml) for 15 days.
Ten DGAT1-transfected clones were isolated by using cloning cylin-
ders and were grown in 100-mm Petri dishes with 10% FBS, MEM plus
G418 antibiotic (300 mg/ml) for 15 days. Triacylglycerol synthetic rate
and content were analyzed in each DGAT-transfected clone, as well as
in empty vector-transfected SV40 cells (Control cells), and two DGAT
clones (DGAT-A and DGAT-V cells) that showed the highest synthesis
of triacylglycerol (measured by the incorporation of [14C]oleate into
lipids during a 24-h period) were selected for the experiments.
Metabolic Labeling—Preconfluent control and DGAT cells, cultured
in 60-mm dishes, were incubated for up to 48 h either with [14C]oleic
acid (0.25 mCi/dish), [3H]glycerol (5 mCi/dish) or [methyl-14C]choline
(0.5mCi/dish), in the presence or absence of 100 mM oleate, in 10% FBS,
MEM supplemented with 0.5% BSA. At the end of each labeling period,
the radioactive medium was discarded and cell monolayers were
washed twice with 0.1% BSA in ice-cold phosphate-buffered saline
(PBS), to eliminate residual label on the cell surface. Next, cells were
scraped from the dishes with two additions of 1 ml of ice-cold methanol
and 0.5 ml of H2O. Total cellular lipids were obtained according to the
procedure of Bligh and Dyer (27) and aqueous and lipid fractions were
concentrated in a Savant SpeedVac concentrator.
Analysis and Quantitation of Lipids and Choline-derived Metabo-
lites—For mass lipid determinations, cells were grown until near con-
fluence in 100-mm dishes and total lipid extracts were obtained as
described above. Neutral and polar lipids species were separated on
Silica Gel 60 thin-layer chromatography (TLC) plates using one-dimen-
sional single development procedures. Routinely, neutral lipid separa-
tion was carried out with the following solvent system:hexane:ethyl
ether:acetic acid, 80:20:2 (by volume). Polar lipid species were resolved
in a solvent system consisting of chloroform:methanol:ammonium hy-
droxide:water, 50:37.5:3.5:2 (by volume). Known amounts of pure lipid
standards were seeded and run on the TLC plates in parallel to sam-
ples. To both solvent systems 100 mM 1,6-diphenyl-1,3,5-hexatriene was
added to visualize the lipid spots on the plate under UV light (22).
Fluorescent lipid spots from samples and standards were photographed
and lipid mass was quantified using a DS120 Kodak Image system. For
the [14C] and [3H] labeling experiments, individual fluorescent lipid
spots were scraped into plastic vials and radioactivity levels were de-
termined in a liquid scintillation counter.
To separate water-soluble choline metabolites, aqueous phases were
dried and dissolved in H2O, spotted on silica gel chromatoplates, and
resolved with 0.6% sodium chloride, methanol, 30% ammonium hydrox-
ide; 50:50:5 (by volume). Pure standards were used as carriers and were
added to the samples before chromatography. Radioactive spots were
detected in a Berthold II radiometric scanner, scraped into vials,
and counted.
Total 1,2-DAG was quantitated by the DAG kinase assay according
to the procedure of Preiss et al. (28), using [g-32P]ATP as substrate. The
results of lipid determinations were expressed in nanomoles of lipid per
mg of protein.
Cell Proliferation—To evaluate cell growth, 1.5 3 104 cells were
seeded in duplicate 60-mm dishes. Twenty-four hours later, medium
was removed and replaced with fresh growing medium. At this time and
up to 144 h cells were then trypsinized, and counted in an hemocytom-
eter. Cell viability was determined by trypan blue exclusion.
[3H]Thymidine Incorporation into Total DNA—To measure the rate
of DNA synthesis, cells grown in triplicate 60-mm dishes were pulsed
with [3H]thymidine (1 mCi/dish) in 2 ml of growing media for 3 h at
37 °C. Media was removed and cell monolayers were washed twice with
ice-cold PBS, and then precipitated with 5% trichloroacetic acid for 10
min at 4 °C. The acid-insoluble material was solubilized with 0.2% SDS
in 0.1 N NaOH and an aliquot was counted in a liquid scintillation
counter.
Cloning in Soft Agar—Control and DGAT cells were plated in qua-
druplicates at 1 3 104 cells per 60-mm dishes in MEM containing 10%
FBS and 0.3% (w/v) agar onto a bottom layer of 0.6 (w/v) agar in MEM.
After 3 and 5 weeks, the presence or absence of multicellular colonies
(more than eight cells) in both cell groups was verified under the
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microscope. For macroscopic analysis, cell colonies were stained with
ethidium bromide in PBS for 30 min, visualized, and photographed
under UV light.
Cell Radiolabeling and Phospholipase Treatments—Near confluent
control and DGAT cells grown in 60-mm dishes were incubated with
trace amounts of [14C]oleic acid (0.25 mCi/dish) in growing medium
supplemented with 0.5% BSA for 48 h. After labeling, medium was
removed and monolayers were washed twice with 0.1% BSA in warm
PBS. Next, cells were treated with 10 units/dish of either PC-PLC or
PLA2, or 100 mM oleic acid, for 6 h. After these treatments, the medium
was discarded, and cell monolayers were washed with ice-cold PBS and
scraped with two additions of ice-cold methanol. Lipid extraction and
separation, as well as the quantitation of radioactivity levels of lipid
species, were performed as stated above.
DGAT Enzyme Assay—Cells were grown in 100-mm Petri dishes
until 80–90% confluence. Cells were then trypsinized, washed twice
with ice-cold PBS, and resuspended in 10 mM Tris-HCl buffer, pH 7.4,
with protease inhibitor mixture (Sigma). Cell homogenates were ob-
tained by sonication on an ice-water bath for 10 s at 50% output and
stored at 270 °C until use. DGAT activity was determined using 100
and 200 mg of cell homogenate protein, 200 mM diacylglycerol in acetone,
and 30 mM [3H]palmitoyl-CoA following the procedure of Coleman (29).
Western Blot Analysis of FLAG-DGAT—Preconfluent control and
DGAT cells were homogenized in 25 mM Tris-HCl, pH 7.4, 1 mM EDTA,
0.1% SDS plus 1% protease inhibitor mixture by sonication in an
ice-water bath. Proteins from total cell homogenates (150 mg) were
separated by SDS-polyacrylamide gel electrophoresis on a 12.5% poly-
acrylamide gel and then transferred onto nitrocellulose membranes.
After blocking, membranes were incubated with mouse anti-FLAG as
primary antibody and donkey anti-mouse IgG-horseradish peroxidase
conjugate as secondary antibody. Visualization of FLAG-DGAT protein
was performed using a SuperSignal West Pico detection kit (Pierce).
Other Methods—Protein content was measured as described by
Lowry et al. (30). [3H]Palmitoyl-CoA was synthesized enzymatically (31).
RESULTS
Stable DGAT Overexpression Results in Massive Accumula-
tion of Triacylglycerol and a Decrease in the Levels of DAG and
PC—From a pool of SV40-transformed cells transfected with
DGAT1 cDNA and selected by resistance to G418 antibiotic
resistance, several clones of DGAT overexpressing cells were
isolated. Two clones, DGAT-A and DGAT-V, which had the
highest rate of TAG synthesis and TAG content were selected
for the experiments. DGAT-A cells exhibited a high level of
FLAG-DGAT protein expression (Fig. 1A), which correlated
with a 3.9-fold increase in the in vitro DGAT activity (Fig. 1B),
when compared with control cells. In addition, the DGAT-V
cells exhibited a 10-fold increase in DGAT activity over the
controls. However, because this DGAT-overexpressing clone
showed an extremely low cell proliferation rate (see below),
because of feasibility, most of the experiments were performed
using the DGAT-A clone.
To determine whether FLAG-DGAT protein was functional
in the whole cells, the content of triacylglycerol mass in control
and DGAT-A cells was analyzed by TLC and densitometric
scanning. Accordingly, DGAT-A cells showed a 3.2-fold in-
crease in triacylglycerol levels, with respect to control cells
(Fig. 1, C and D). These cells also exhibited a higher level of
cholesteryl esters, but this finding was not further investi-
gated. We also observed that triacylglycerol accumulated as
numerous small cytosolic droplets (Oil Red O sensitive) sur-
rounding the nucleus (data not shown). This pattern of triacyl-
glycerol depot was similar to that observed in other non-adi-
pose cells (32), indicating that no aberrant localization of
triacylglycerol droplets occurred in the DGAT-overexpressing
cells. Taken as a whole, this group of observations indicate that
the DGAT-transfected clones contained high amounts of func-
tional DGAT enzyme that promoted the accumulation of its
product triacylglycerol.
Additionally, the mass of the main phospholipids, PC and
PE, as well as 1,2-DAG was determined in control cells and
DGAT overexpressors (Table I). PC content decreased ;20% in
DGAT-A cells compared with empty vector-transfected SV40
cells, whereas the levels of PE did not show significant changes
between the cell groups. Interestingly, the content of total
1,2-DAG in DGAT cells was reduced by 70% with respect to
control values, strongly suggesting that the overexpressed
DGAT activity is depleting the DAG sources that can be used
for phospholipid production by preferentially channeling this
lipid intermediate into triacylglycerol stores.
Synthesis of Neutral Lipids Versus Polar Lipids in DGAT
Overexpressing Cells: Regulation of Lipid Partitioning by
DGAT—Because it has been hypothesized that PC and triacyl-
glycerol biosynthetic pathways share the same pool of lipid
substrates, we analyzed both the synthesis of neutral and polar
lipids in control and DGAT-overexpressing cells incubated with
traces of [14C]oleic acid. Labeling of total lipids was slightly
decreased (;20%) in DGAT-A cells compared with controls.
When the synthesis of the [14C]lipid species was analyzed, it
was observed that the formation of triacylglycerol was 2.3- and
5.5-fold higher in DGAT cells than in control cells at 24 and
48 h, respectively (Fig. 2A). On the other hand, synthesis of
total polar lipids was decreased by 35% in DGAT overexpres-
sors, both at 24 and 48 h (Fig. 2B). Decreases in both PC and
PE, the only polar lipid species labeled with [14C]oleate in both
cell groups, accounted for the lower phospholipid labeling (data
not shown). Additionally, the levels of cellular [14C]1,2-DAG,
measured after a 24-h incubation with trace amounts of
[14C]oleate, was ;30% decreased in DGAT cells compared with
empty vector-transfected cells (6694 6 836 versus 4602 6 608
dpm/mg of protein, respectively). This observation further con-
firms that DGAT overexpression preferentially redirects DAG
molecules toward the synthesis of triacylglycerol, decreasing
the DAG pool available for the formation of phospholipids.
Oleic acid can act as a substrate for both acylation of pre-
existing phospholipids as well as for the de novo synthesis of
polar lipids, whereas labeled glycerol is a substrate exclusively
for the de novo synthetic pathway, therefore labeling of lipids
with [3H]glycerol would help to determine whether this route is
specifically affected by DGAT overexpression. Thus, preconflu-
ent control and DGAT-A cells were labeled with [3H]glycerol for
24 h in the presence of 100 mM oleate to enhance lipid synthesis,
and labeled neutral and total phospholipids were analyzed. The
incorporation of [3H]glycerol into total cell lipids was signifi-
cantly depressed in DGAT cells compared with the mock-trans-
fected group (Fig. 3), suggesting a specific down-regulation of
the de novo pathway for glycerolipid formation in the DGAT
overexpressors. However, despite a decreased de novo lipid
formation, most of the [3H]glycerol was incorporated into tri-
acylglycerol in DGAT cells at the expense of both PC and PE
labeling (Fig. 3, inset), indicating that de novo synthesized lipid
substrates were re-directed toward the synthesis of triacylglyc-
erol in the DGAT-SV40 cells.
Decreased de Novo Synthesis of PC and SM in DGAT Over-
expressors—Because both the [14C]oleic acid and [3H]glycerol
experiments pointed to a deficit in the synthesis of the lipid
backbone of phospholipids, we examined the synthesis of the
polar head for PC using [14C]choline as tracer. After incubating
the monolayers with [14C]choline for 24 h, labeled lipids and
choline aqueous metabolites were analyzed. As shown in Fig.
4A, synthesis of PC and SM was 38 and 30% lower, respec-
tively, in DGAT cells than in controls, in agreement with the
[14C]oleate and [3H]glycerol experiments. More than 90% of the
water-soluble choline metabolites was phosphorylcholine (Fig.
4C) and DGAT cells had 30% less phosphorylcholine than
mock-transfected controls. DGAT overexpressors showed a ;9-
fold increase in [14C]CDP-choline compared with the control
cells (Fig. 4D). This unusual accumulation of CDP-choline,
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together with the decreased formation of [14C]choline-labeled
PC, strongly indicates a deficient level of the co-substrate DAG
available for the CDP-choline diacylglycerol phosphotrans-
ferase reaction.
Formation of Triacylglycerol from DAG and Fatty Acids Re-
leased from Plasma Membrane Is Enhanced by DGAT Overex-
pression—We have previously shown that DAG derived from
turnover of plasma membrane phospholipids is converted to
FIG. 1. High levels of DGAT expression and activity induce massive accumulation of triacylglycerol in SV40-transformed fibro-
blasts stably transfected with FLAG-DGAT cDNA. Near confluent empty vector-transfected (Control) and DGAT cells were scraped and
homogenized by sonication. FLAG-DGAT protein expression levels (A) were analyzed by Western blot in duplicate samples of DGAT-A cells using
anti-FLAG antibody. DGAT activity (B) was measured in triplicate or quadruplicate samples of DGAT-A and DGAT-V cells using [14C]palmitoyl-
CoA and diacylglycerol as substrates. Cell triacylglycerol (TAG) content (C and D) were determined in quadruplicate samples of the DGAT-A cell
clone by TLC followed by scanning densitometry. CHOL, cholesterol.
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triacylglycerol (22), suggesting a role for DGAT in the metab-
olism of signaling lipids. To determine whether overexpression
of DGAT would enhance the channeling of plasma membrane-
released lipids toward triacylglycerol formation, membrane
phospholipids of DGAT-A and control cells were prelabeled
with trace amounts of [14C]oleic acid for 48 h and, after cell
monolayers were treated with either PC-PLC or PLA2 for 6 h,
the formation of [14C]triacylglycerol was estimated. As shown
in Fig. 5, in cells exposed to bacterial PC-PLC, the synthesis of
new triacylglycerol was increased 6.2-fold in DGAT cells com-
pared with the control group, confirming that DGAT can use
membrane-released signaling DAG to produce triacylglycerol.
Additionally, DGAT cells incubated with PLA2 exhibited a 2.8-
fold increase in [14C]triacylglycerol labeling, indicating that
fatty acids originating from the plasma membrane are also
substrates for DGAT activity.
Effects of DGAT Stable Overexpression on Cell Proliferation
and Colony Forming Ability—Given the fact that overex-
pressed DGAT could reduce phospholipid synthesis and se-
quester membrane-released lipids with potential signaling
functions into triacylglycerol, we addressed the question of
whether cell growth was affected by these alterations in lipid
metabolism. Fig. 6 shows the growth curve for the normal
human lung fibroblast WI38 strain, non-transfected SV40-
transformed WI38 cells, and SV40 cells stably transfected with
either DGAT cDNA or empty vector. As expected, the neoplas-
tic SV40 cells, both non-transfected and transfected with vector
only, displayed a much faster growth rate than the normal
fibroblasts. Remarkably, DGAT-A and DGAT-V cell clones
grew at a rate even slower than normal WI38 fibroblasts.
Moreover, the growth rate of the DGAT clones was inversely
correlated to their DGAT activities (Fig. 1A), having the
DGAT-V cells with the highest DGAT activity and the lowest
cell replication rate. Additionally, the DNA synthesis rate was
compared between mock and DGAT-transfected SV40 cells
(Fig. 7). The incorporation of [3H]thymidine into cellular DNA
was 50% lower in DGAT overexpressors with respect to empty
vector-transfected controls, confirming the profound effect of
DGAT overexpression on cell growth properties of the neoplas-
tic SV40 cells.
To further analyze whether the decreased growth rates in
DGAT-overexpressing neoplastic cells was accompanied by
other modifications in the transformation phenotype, control
and DGAT-A cells were tested for their abilities to form colo-
nies on a soft agar surface. Cells were grown on agar for 21
days and up to 5 weeks, to allow the formation of colonies of
more than eight cells. Whereas empty vector-transfected cells
produced multiple colonies after 21 days incubation, DGAT
overexpression completely eliminated the anchorage-indepen-
dent growth of the neoplastic SV40 cells (Fig. 8). Moreover, the
DGAT cells were not able to produce colonies of more than 3–5
cells even after 5 weeks of incubation (data not shown).
DISCUSSION
Much of the interest in the regulation of triacylglycerol syn-
thesis, and specially DGAT activity, relates to its role in storing
energy. Excessive depots of triacylglycerols in adipose cells is
strongly related to the development of lipid dysmetabolism-
related disorders such as obesity and type 2 diabetes, diseases
currently considered epidemic in Western countries. However,
in cells in which neutral lipids are not primarily used as energy
store, new functions for both triacylglycerols and DGAT have
been identified. In human skin fibroblasts, triacylglycerol
can act as a donor of lipid precursors, mostly DAG and fatty
TABLE I
Levels of PC, PE, and 1,2-DAG in control and DGAT-A cells
SV40-transformed cells stably transfected with either empty vector
(Control) or DGAT1 cDNA (DGAT-A) were grown until near confluence
in MEM, 10% FBS in the presence of 300 mg/ml geneticin. Cells were
harvested and the content of lipid species was determined as described
under “Experimental Procedures.” Values represent mean 6 S.D. of
three separate determinations (PC and PE) or the average of duplicate
determinations for two independent experiments, with a difference
between determinations of less than 10% (1,2-DAG).
Nanomole of lipid/mg protein Control DGAT-A
PC 156 6 14 121 6 16a
PE 58 6 12 67 6 11
1,2-DAG 0.409 0.116
a p , 0.05, Student’s t test.
FIG. 2. Incorporation of [14C]oleic acid into triacylglycerol (A)
and total phospholipids (B) in control and DGAT-A cells. Cells
were incubated with 0.25 mCi of [14C]oleic acid in 0.5% BSA, 10% FBS,
MEM for 24 and 48 h. Lipids were extracted and chromatographed as
described under “Experimental Procedures.” Data points represent the
mean 6 S.D. of an experiment performed in triplicate (24 h) and
duplicate (48 h). Variation between duplicates was less than 5%.
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acids, for the synthesis of new membrane phospholipids (2).
In Chinese hamster ovary cells, the accumulation of triacyl-
glycerol contributes to protect the cells against saturated
fatty acid-induced apoptosis (33). On the other hand, the
accumulation of triacylglycerols in pancreatic islet cells has
been linked to a dysregulation of insulin secretion (26) and
programmed cell death (34, 35). Nevertheless, the mechanisms
by which triacylglycerols modulate these functions are poorly
understood.
Another aspect of the non-energetic functions of triacylglyc-
erols, mainly related to cellular signaling and membrane for-
mation, is the potential role that DGAT might play in control-
ling DAG levels within the cell. We have shown that DAG
released from plasma membrane of Chinese hamster ovary
cells is mainly used as a substrate for DGAT in triacylglycerol
synthesis (22). However, this new regulatory role for DGAT has
not been directly tested. The isolation of cDNAs encoding two
DGAT isoforms (23, 24) provides molecular tools to evaluate
the role of triacylglycerol synthesis as a modulator of DAG
levels and as a possible mechanism to sequester excess DAG
signal into triacylglycerol stores. To study these potential roles
of DGAT, we developed a stable DGAT1-overexpressing mam-
malian cell model based on SV40-transformed human lung
fibroblasts, which contain high levels of intracellular DAG (12)
and enhanced lipid synthesis for building new membranes.2
The stable transfection of SV40 cells with mouse DGAT cDNA
resulted in a severalfold increase in both expression and activ-
ity of DGAT, and a 3-fold increase in triacylglycerol content.
Interestingly, in addition to this small accumulation of triacyl-
glycerol, DGAT overexpression depressed the synthesis of
membrane phospholipids, presumably by preferentially chan-
neling lipid substrates into triacylglycerol instead of phospho-
lipid. Our data indicate that DGAT, indeed, can control the flow
of lipid substrates used for the synthesis of both triacylglycerol
and phospholipids, thereby regulating the balance between the
formation of neutral and polar lipids for energetic, structural
and signaling purposes. This conclusion is based on the fact
that the great accumulation of triacylglycerol promoted by
DGAT overexpression concurred with decreased levels of 1,2-
DAG and PC, demonstrating that DGAT was segregating DAG
destined to phospholipid synthesis. Furthermore, the massive
synthesis of triacylglycerol that took place in DGAT cells (2.3-
and 5.5-fold more [14C]oleic acid incorporated into triacylglyc-
erols compared with mock-transfected SV40 cells) occurred in
parallel to a deficient production of phospholipids. Thus, while
phospholipid synthesis from [14C]oleate was significantly de-
creased in DGAT cells, the incorporation of [14C]oleic acid into
total lipids remained essentially similar between the two cell
groups, indicating that a 3-fold increase in DGAT activity could
regulate the synthesis and remodeling of phospholipid without
altering the rate of uptake of exogenous fatty acids. Addition-
ally, [3H]glycerol-labeled lipid substrates were preferentially
incorporated into triacylglycerol in DGAT cells, indicating that
DGAT was also capable of regulating the partitioning of endo-
genously synthesized lipids. This observation also confirms the
existence of pools of lipid substrates, originated from either
endogenously or exogenously sources, that are equally avail-
able for both polar and neutral lipid synthesis. In our DGAT-
overexpressing SV40 cells, the redirection of lipid intermedi-
ates toward triacylglycerols appears to lead to substrate
deprivation for phospholipid synthesis. Thus, DGAT cells
formed less PC from [14C]choline than controls and accumu-
lated CDP-choline, suggesting that the amount of DAG avail-
able was unable to sustain the terminal reaction for PC syn-
thesis. The significant decrease in 1,2-DAG content together
with the lower levels of [14C]oleate-labeled 1,2-DAG found in
DGAT-overexpressing cells with respect to mock transfected
controls confirms this hypothesis. A similar regulatory effect of
DAG levels on the rate of PC synthesis was observed when
choline-phosphate cytidylyltransferase was overexpressed in
COS cells (36). In the choline-phosphate cytidylyltransferase-
overexpressing cells, a 100-fold higher choline-phosphate cyti-
dylyltransferase activity led to only a modest increase in PC
synthesis, despite a 12-fold elevation in CDP-choline content;
this was attributed to a limiting supply of DAG. Together,
these findings corroborate that DGAT, by preferentially using
lipid substrates for glycerolipid synthesis, exhausts the source
of substrates, mainly DAG, for phospholipid formation.
In association with the significant changes promoted in lipid
metabolism, the overexpression of DGAT in SV40 neoplastic
cells had profound effects on cell growth. The growth rate of
DGAT cells was significantly decreased and was even slower
than the normal parental fibroblasts. More strikingly, DGAT
overexpression also eliminated anchorage-independent growth,
another feature of neoplastic transformation. The altered
growth pattern of DGAT-overexpressing SV40 cells (cell divi-
sion and anchorage-independent growth) are unlikely to be
caused solely by accumulation of triacylglycerol. For example,
neutral lipid storage disease fibroblasts contain ;20 times
more triacylglycerol than normal cells (2) but have similar
growth rate.3 In addition, stable overexpression of mitochon-
drial GPAT in Chinese hamster ovary cells led to a 4-fold
accumulation of triacylglycerol and a reduced formation of
phospholipids with no change in the rate of cell proliferation
(37).
Both the slow cellular proliferation and loss of the DGAT-
overexpressing SV40 cells capacity to grow in soft agar might
be caused by either the deprivation of essential DAG substrate
2 J. M. Caviglia and R. A. Igal, unpublished observations. 3 R. A. Igal and R. A. Coleman, unpublished observations.
FIG. 3. DGAT overexpression inhibits the incorporation of
[3H]glycerol into total lipids. Preconfluent DGAT-A and control
SV40 cells grown in 10% FBS, MEM were labeled with 5 mCi of [3H]-
glycerol in the presence of 100 mM oleate for 24 h. Total cell lipids were
isolated and their radioactivity levels were determined by scintillation
counting. Triacylglycerol (TAG), PC, and PE (inset) were separated by
TLC. Each bar represents the mean 6 S.D. for three 60-mm dishes.
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for phospholipid synthesis required to sustain rapid membrane
biogenesis and/or by an alteration in the DAG-activated signal-
ing network related to cell proliferation. The synthesis of mem-
brane structural lipids is active in the SV40-transformed hu-
man lung fibroblasts; we have observed a 2-fold higher de novo
formation of phospholipid and cholesterol in the neoplastic cells
compared with their precursor WI38 human fibroblasts.2
FIG. 4. DGAT overexpression de-
creases the synthesis of [14C]choline-
labeled PC and SM and promotes the
accumulation of [14C]CDP-choline.
Control and DGAT SV40-transformed
cells (DGAT-A clone) were grown in 10%
FBS, MEM until near confluency and
were labeled with 2 mCi/dish of [14C]cho-
line for 6 h in growing media. Aqueous
and chloroform phases were extracted
and analyzed as stated under “Experi-
mental Procedures.” Each bar expresses
the mean 6 S.D. of one experiment per-
formed in triplicate. Panels A, [14C]PC
and [14C]SM; B, [14C]choline; C, [14C]-
phosphorylcholine; D, [14C]CDP-choline.
FIG. 5. DGAT overexpression stimulates the formation of tria-
cylglycerols from DAG and fatty acids released from plasma
membrane. Near confluent control and DGAT-A cells were labeled to
steady-state (48 h) with 0.25 mCi/dish of [14C]oleic acid. Next, cells
monolayers were treated with 10 units/dish PC-PLC or PLA2 for up to
6 h. Data are expressed as disintegrations/min of [14C]triacylglycerol
formed during the period of phospholipase treatment. Values represent
two or three independent determinations, each performed in duplicate.
Variability between duplicates was 5–7%.
FIG. 6. DGAT overexpression slows the proliferation rate of
SV40-transformed cells. Normal human lung fibroblasts (WI38) and
SV40-transformed WI38 fibroblasts (wild type, stably transfected with
either empty vector (Control) or with DGAT cDNA (DGAT-A and
DGAT-V)), grown in 10% FBS, MEM, were seeded in 60-mm plates.
Cells were then trypsinized and counted at time points up to 144 h.
Data represents the average of duplicate determinations and variability
between duplicates was less than 10%. Results reported are represent-
ative of three independent experiments.
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On the other hand, the finding that DGAT-overexpressing
cells had a reduced synthesis of the major phospholipids be-
cause of a limited supply of DAG is surprising, because the cell
media contained a sufficient concentration of the different sub-
strates needed for phospholipid synthesis. Moreover, the inclu-
sion of 100 mM oleate in the incubation media to enhance the
formation of DAG substrates for lipid synthesis failed to nor-
malize phospholipid synthesis, thereby indicating that de-
creased phospholipid formation is not exclusively produced by
the lack of DAG and/or fatty acid substrates. In addition, the
lower synthesis of [3H]glycerol-labeled lipids in the DGAT cells
indicates that these cells were not able to increase the de novo
formation of DAG to compensate phospholipid synthesis. This
observation is intriguing because the high de novo synthesis of
lipids exhibited by the SV40-transformed cells3 and other neo-
plastic cell strains (38) compared with normal cell strains,
could provide sufficient substrates for phospholipid synthesis.
However, a deficiency of PC formation caused by DGAT over-
expression could be responsible for normalizing the transfor-
mation phenotype of SV40 cells. In this regard, it was reported
that the pharmacological inhibition of PC synthesis promotes a
slower cell proliferation rate and loss of actin fiber organization
in A549 adenocarcinoma cells (39), as well as inhibition of
invasiveness in mouse lymphoma cells (40).
The lack of compensatory up-regulation of de novo DAG
synthesis for phospholipid formation raises the question of
whether DGAT overexpression is altering the cell growth prop-
erties by merely redirecting DAG molecules destined to phos-
pholipid synthesis toward triacylglycerol synthesis. Results
from our experiments support a role for DGAT in cell regula-
tion by its ability to modulate the levels of intracellular signal-
ing DAG and fatty acids. Neoplastic transformation in SV40
cells is associated with increased DAG levels and low content of
ceramide (12). The constitutive elevation in intracellular DAG
content during SV40 transformation led to NF-kB activation,
probably mediated by DAG-stimulated PKC activity (41). Thus,
the PKC system must be dysregulated in DGAT-overexpress-
ing SV40 cells, which exhibit DAG levels lower than mock-
transfected SV40 cells. One possible major candidate for down-
regulation is PKC-a, a ubiquitous DAG-dependent isoform
implicated in several biological functions including cell growth,
control of cell cycle and cell shape, and motility (42). In addi-
tion, PKC-a activity seems essential to sustain the tumorige-
nicity of neoplastic cells. In this regard, human lung carcinoma
cells that have a high activity of PKC-a have an increased
capacity for invasion and antisense PKC-a expression reverses
the transformed phenotype of these cells (43). However, other
signaling proteins activated by DAG could also be affected by
DGAT overexpression. In this regard, it has been reported that
DAG kinase z phosphorylates specifically localized DAG mole-
cules, thereby controlling the activation of the DAG-activated
signaling protein RasGRP and H-Ras (20). DAG kinase z
isozymes can regulate local DAG signals; whether other en-
zymes like DGAT or DAG lipases that process DAG molecules
participate in regulating DAG-activated signals is unknown.
In summary, we found out that DGAT-overexpressing neo-
plastic cells show: 1) oversynthesis of triacylglycerol, a decrease
in the intracellular levels of DAG, and diminished acylation
and de novo synthesis of the main phospholipids, PC and PE,
and SM; 2) a high rate of incorporation of DAG and fatty acids
released from plasma membrane phospholipids by phospho-
lipase treatment into triacylglycerol; 3) decreased DNA synthe-
sis and cell proliferation rate; and 4) total inhibition of anchor-
age-independent cell growth. Taken as a whole, this study
provides strong evidence on a novel role of DGAT in the regu-
lation of cellular growth by modulating membrane biogenesis
and terminating intracellular lipid signals.
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